In what may now seem like distant memories, Moderna was one of the heroes of the Covid era, bringing their mRNA based Spikevax vaccine to Europe less than a year after lockdowns were first implemented.
The US-based company had gone public on the NASDAQ just a few years earlier in 2018 and broke records as the biggest biotech IPO at the time. This record has since been broken by Sana Biotechnology in 2021, Kailera Therapeutics in early 2026 and most recently by Parabilis Medicines who raised a whopping $670 million on 10 June 2026.
